CPC A61K 31/4174 (2013.01) [A61K 9/006 (2013.01); A61K 9/2027 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01)] | 6 Claims |
1. A method of treating agitation in an agitated subject, said agitated subject having schizophrenia, consisting of administering to the oral mucosa of said agitated subject one or two single dosage administrations of 60 micrograms of dexmedetomidine or a pharmaceutically acceptable salt thereof without also causing significant sedation after the administration, wherein the dexmedetomidine or the pharmaceutically acceptable salt thereof produces an anti-agitation effect in less than about 60 minutes after administration; wherein the agitation is not perioperative agitation; and wherein said dexmedetomidine or a pharmaceutically acceptable salt thereof is administered in a solid, water-soluble dosage form and wherein the dosage form is a film.
|